other material
confidence high
sentiment neutral
materiality 0.35
Co-Diagnostics amends equity distribution agreement, adds Clear Street as sales agent, up to $17.1M remaining
Co-Diagnostics, Inc.
- Amended equity distribution agreement adds Clear Street LLC as sales agent alongside Piper Sandler, effective April 25, 2025.
- Aggregate offering price up to $17,111,650 remains available; Co-Diagnostics had sold 833,806 shares under prior $50M facility.
- Sales agents receive 3.0% commission on gross sales price; reimbursement capped at $125k setup, $35k execution, $54k for Q3 2024, and $15k per subsequent quarter.
- ATM sales to be made on Nasdaq; settlement on first business day after sale; no escrow arrangement.
- Company will report quarterly the number of shares sold and net proceeds from the program.